Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01766739
Recruitment Status : Active, not recruiting
First Posted : January 11, 2013
Last Update Posted : January 18, 2019
Sponsor:
Collaborator:
Genelux Corporation
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : January 2020
  Estimated Study Completion Date : January 2020